The Latest: Japan to purchase antibody cocktail for COVID-19
|
May 11, 2021 7:25 AM
TOKYO — Japan’s government said Monday that it has agreed to purchase an antibody cocktail to be produced and marketed for COVID-19 treatment by a Japanese drug maker Chugai Pharmaceutical Co. which has a licensing deal with Roche.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
